skip to content

Send To A Friend

Complete the form below to send this news item to a friend. Redmayne-Bentley respect your privacy and do not store your, or your friend's details.

Director Deals - Shield Therapeutics Plc (STX) 05/10/2017
Carl Sterritt, Chief Executive Officer, bought 8,814 shares in the company on the 4th October 2017 at a price of 100.00p. The Director now holds 10,075,261 shares. NOTE: Call option Story provided

Your Details:
Your Friend's Details:

Info Point:

We do not store details of you or the person to whom you are sending a message.

Read more about our Privacy Policy.

Client Area Access

» Secure Login

» Not registered yet?